Education events sponsorship opportunities
If you are interested in sponsorship opportunities, see how you can support the development of cancer education and patient care.
Read Education events sponsorship opportunities ArticleThis study day will focus on important new approaches to management of patients with early breast cancer. Topics will include all aspects of the patient pathway including surgery, endocrine, Immune and targeted therapies, radiotherapy and the prevention and management of treatment toxicities.
All health care professionals that work with breast cancer patients or who have an interest in breast cancer, including specialist registrars (SpRs) and consultant oncologists, GPs, community nurses, nurse specialists and research nurses.
All tickets (on-site and virtual) include access to the event recordings, resources and presentations for up to 6 months post-event date.
Sign up for the A spotlight on early breast cancer study day on Eventbrite today
Time | Session |
---|---|
9.15 | Registration |
10.00 | Advances in breast radiotherapy Dr Carmel Anandadas, Consultant Clinical Oncologist, The Christie NHS Foundation Trust |
10.20 | Recent advances In surgical management of the axilla Mr Ashu Gandhi, Consultant Breast and Endocrine Surgeon, Manchester University Hospital NHS Trust |
10.45 | HER2 positive disease - Advances In HER2 positive breast cancer Dr Ciara O’Brien, Consultant Medical Oncologist, The Christie NHS Foundation Trust |
11.15 - break
Time | Session |
---|---|
11.30 | Immunotherapy in the management of early breast cancer Dr Tim Robinson, Clinical Senior Lecturer in Medical Oncology, University of Bristol and Honorary Consultant Medical Oncologist, UHBW |
12.30 - lunch
Time | Session |
---|---|
13.15 | Management of bone health in breast cancer patients Dr Claire Higham, Consultant Endocrinologist, The Christie NHS Foundation Trust |
13.40 | Endocrine therapy side effects - Updates in management approaches Mrs Nicola Stubbs, Senior Macmillan Clinical Nurse Specialist |
14.05 | Treatment of high-risk ER+ early breast cancer: Abemaciclib, Olaparib and beyond Dr Caroline Wilson, Consultant Medical Oncologist, The Christie NHS Foundation Trust |
14.30 - break
Time | Session |
---|---|
15.00 | Fertility and pregnancy in early breast cancer Dr Anne Armstrong, Consultant Medical Oncologist, The Christie NHS Foundation Trust |
15.30 | Mainstream genetic testing and preventative therapy Dr Sacha Howell, Clinical Senior Lecturer, University of Manchester and Honorary Consultant Medical Oncologist, The Christie NHS Foundation Trust |
16.00 - close
If you are interested in sponsorship opportunities, see how you can support the development of cancer education and patient care.
Read Education events sponsorship opportunities Article© 2024 The Christie NHS Foundation Trust